A future tool for the treatment of the disease of obesity
Activation of GLP-1R by GLP-1 or other exogenous agonists, including exendin-4 and liraglutide, decreases inflammatory responses in several animal models like rat heart and whole animal model
Talk to your Coryell Health primary care provider about which variety of GLP-1 medication would be best for you
Contact your GP or diabetes specialist nurse within 2448 hours if: The injection site reaction persists beyond one week or worsens progressively You develop signs of infection at the injection site (increasing pain, warmth, pus, or red streaking) The rash spreads beyond the injection site but without severe symptoms You experience recurrent reactions with each injection The reaction significantly impacts your quality of life or ability to continue treatment If you cannot reach your GP and need urgent advice, contact NHS 111
The Precision Peptide Genetic Test examines 14 metabolic pathways, including MC4R variants involved in temperature regulation and energy expenditure
If headaches persist or become severe, consulting with a healthcare provider is recommended
